全球診斷劑市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計診斷劑市場將從 2025 年的 655.5 億美元成長到 2034 年的 1,202.1 億美元，2026 年至 2034 年的複合年成長率為 6.97%。

受對精準早期疾病檢測需求不斷成長的推動，全球診斷劑市場持續穩定擴張。感染疾病、癌症和慢性病的日益流行，加速了醫院和實驗室對診斷試劑盒和試劑的使用。臨床檢測量的成長，尤其是在後疫情時代，進一步鞏固了全球市場的發展趨勢。

分子診斷、免疫檢測和就地檢驗技術的進步是成長要素。人口老化和日益增強的健康意識也進一步促進了診斷檢測率的提升。此外，新興經濟體政府為加強檢查室基礎設施建設和擴大篩檢計畫所做的努力，也為市場的永續發展做出了貢獻。

展望未來，自動化、個人化醫療和人工智慧整合診斷平台的進步預計將對市場產生積極影響。試劑配方的持續創新和伴隨診斷的日益普及將支撐市場的長期成長。居家檢測和快速檢測解決方案的推廣預計將在未來幾年開闢新的收入來源。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球診斷劑市場：依產品類型分類

• 市場分析、洞察與預測
• 層析法試劑
• 分子診斷劑
• 免疫檢測試劑
• 臨床化學試劑
• 流式細胞技術試劑
• 細胞和組織培養試劑
• 血液學和止血試劑
• 微生物試劑
• 其他

第5章 全球診斷劑市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院和診斷檢查室
• 學術研究機構
• 其他

第6章 全球診斷劑市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 亞太其他地區
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Becton Dickinson And Company
  • Siemens Healthineers
  • Sysmex Corporation
  • DiaSorin SPA
  • BioMerieux SA
  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific Inc
  • Agilent Technologies Inc

The Diagnostic Reagents Market size is expected to reach USD 120.21 Billion in 2034 from USD 65.55 Billion (2025) growing at a CAGR of 6.97% during 2026-2034.

The Global Diagnostic Reagents Market is witnessing steady expansion due to the increasing demand for accurate and early disease detection. Rising prevalence of infectious diseases, cancer, and chronic disorders has accelerated the use of diagnostic kits and reagents across hospitals and laboratories. Growth in clinical testing volumes, especially post-pandemic, continues to strengthen market momentum worldwide.

Key drivers include advancements in molecular diagnostics, immunoassays, and point-of-care testing technologies. The growing elderly population and increasing healthcare awareness are further boosting diagnostic testing rates. Additionally, government initiatives to enhance laboratory infrastructure and expand screening programs in emerging economies are contributing to sustained market development.

Looking ahead, the market is expected to benefit from automation, personalized medicine, and AI-integrated diagnostic platforms. Continuous innovation in reagent formulations and the rising adoption of companion diagnostics will support long-term growth. Expansion of home-based and rapid testing solutions is likely to open new revenue streams in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Chromatography Reagents
• Molecular Diagnostic Reagents
• Immunoassay Reagents
• Clinical Chemistry Reagents
• Flow Cytometry Reagents
• Cell And Tissue Culture Reagents
• Hematology And Hemostasis Reagents
• Microbiology Reagents
• Others

By End-user

• Hospitals And Diagnostics Laboratories
• Academic And Research Institutes
• Others

COMPANIES PROFILED

• Abbott Laboratories, F HoffmannLa Roche AG, Becton Dickinson and Company, Siemens Healthineers, Sysmex Corporation, DiaSorin SpA, bioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific Inc, Agilent Technologies Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIAGNOSTIC REAGENTS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Chromatography Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Molecular Diagnostic Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Immunoassay Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Clinical Chemistry Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Flow Cytometry Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Cell And Tissue Culture Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Hematology And Hemostasis Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Microbiology Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIAGNOSTIC REAGENTS MARKET: BY END-USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-user
• 5.2. Hospitals And Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIAGNOSTIC REAGENTS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product Type
  • 6.2.2 By End-user
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product Type
  • 6.3.2 By End-user
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product Type
  • 6.4.2 By End-user
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product Type
  • 6.5.2 By End-user
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product Type
  • 6.6.2 By End-user
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL DIAGNOSTIC REAGENTS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Abbott Laboratories
  • 8.2.2 F. Hoffmann-La Roche AG
  • 8.2.3 Becton Dickinson And Company
  • 8.2.4 Siemens Healthineers
  • 8.2.5 Sysmex Corporation
  • 8.2.6 DiaSorin S.P.A
  • 8.2.7 BioMerieux SA
  • 8.2.8 Ortho Clinical Diagnostics
  • 8.2.9 Thermo Fisher Scientific Inc
  • 8.2.10 Agilent Technologies Inc